Skip to main content
Top
Published in: European Journal of Epidemiology 4/2010

Open Access 01-04-2010 | PHARMACO-EPIDEMIOLOGY

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies

Authors: B. H. Ch. Stricker, T. Stijnen

Published in: European Journal of Epidemiology | Issue 4/2010

Login to get access

Abstract

In pharmaco-epidemiology, the use of drugs is the determinant of interest when studying exposure-outcome associations. The increased availability of computerized information about drug use on an individual basis has greatly facilitated analyses of drug effects on a population-based scale. It seems likely that many negative findings in the early days of pharmaco-epidemiology can be explained by non-differential misclassification because of too simple (yes/no) exposure measures. In this paper, the authors discuss the importance of an adequate definition of drug exposure in pharmaco-epidemiological research and how this time-varying determinant can be analyzed in cohort studies. To reduce the risk of non-differential misclassification, a precise definition of exposure is mandatory and it is important to distinguish the complete follow-up period of a population into mutually exclusive episodes of non-use, past use and current use for each individual. By analyzing exposure to drugs as a time-dependent variable in a Cox regression model, cohort studies with complete coverage of all filled prescriptions can provide us with valid and precise risk estimates of drug-outcome associations. However, such estimates may be biased in the presence of time-dependent confounders which are themselves affected by prior exposure.
Literature
1.
go back to reference IEA-EEF European Congress of Epidemiology 2009 Warsaw, Poland 26–29 August. Eur J Epidemiol 2009;24 Suppl 1. IEA-EEF European Congress of Epidemiology 2009 Warsaw, Poland 26–29 August. Eur J Epidemiol 2009;24 Suppl 1.
2.
go back to reference Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284:878–81.PubMedCrossRef Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284:878–81.PubMedCrossRef
3.
go back to reference Hurwitz ES, Barrett MJ, Bregman D, et al. Public health service study of Reye’s syndrome and medications. Report of the main study. JAMA. 1987;257:1905–11.CrossRefPubMed Hurwitz ES, Barrett MJ, Bregman D, et al. Public health service study of Reye’s syndrome and medications. Report of the main study. JAMA. 1987;257:1905–11.CrossRefPubMed
4.
go back to reference Heinonen OP, Shapiro S, Tuominen L, Turunen MI. Reserpine use in relation to breast cancer. Lancet. 1974;2:675–7.CrossRefPubMed Heinonen OP, Shapiro S, Tuominen L, Turunen MI. Reserpine use in relation to breast cancer. Lancet. 1974;2:675–7.CrossRefPubMed
5.
6.
go back to reference MacMahon B. Prenatal X-ray exposure and childhood cancer. J Nat Cancer Inst. 1962;28:1173.PubMed MacMahon B. Prenatal X-ray exposure and childhood cancer. J Nat Cancer Inst. 1962;28:1173.PubMed
7.
go back to reference Buring JE, Bain CJ, Hennekens CH. Alternative data sources in a case-control study of conjugated estrogens and cancer. Am J Prev Med. 1986;2:116–21.PubMed Buring JE, Bain CJ, Hennekens CH. Alternative data sources in a case-control study of conjugated estrogens and cancer. Am J Prev Med. 1986;2:116–21.PubMed
8.
go back to reference Perneger TV, Whelton PK, Klag MJ. Risk of kiney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Eng J Med. 1994;331:1675–9.CrossRef Perneger TV, Whelton PK, Klag MJ. Risk of kiney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Eng J Med. 1994;331:1675–9.CrossRef
9.
go back to reference Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242:644–8.CrossRefPubMed Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242:644–8.CrossRefPubMed
10.
go back to reference Winkelmayer WC, Bucsics AE, Schautzer A, Wieninger P, Pogantsch M. Use of recommended medications after myocardial infarction in Austria. Eur J Epidemiol. 2008;23:153–62.CrossRefPubMed Winkelmayer WC, Bucsics AE, Schautzer A, Wieninger P, Pogantsch M. Use of recommended medications after myocardial infarction in Austria. Eur J Epidemiol. 2008;23:153–62.CrossRefPubMed
11.
go back to reference Hsia Y, Maclennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK. Eur J Epidemiol. 2009;24:211–6.CrossRefPubMed Hsia Y, Maclennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK. Eur J Epidemiol. 2009;24:211–6.CrossRefPubMed
12.
go back to reference Thompson A. Thinking big: large-scale collaborative research in observational epidemiology. Eur J Epidemiol. 2009;24:727–31.CrossRefPubMed Thompson A. Thinking big: large-scale collaborative research in observational epidemiology. Eur J Epidemiol. 2009;24:727–31.CrossRefPubMed
13.
go back to reference Groenwold RHH, Hoes AW, Hak E. Confounding in publications of observational intervention studies. Eur J Epidemiol. 2008;22:413–5.CrossRef Groenwold RHH, Hoes AW, Hak E. Confounding in publications of observational intervention studies. Eur J Epidemiol. 2008;22:413–5.CrossRef
14.
go back to reference Stang A. Appropriate epidemiologic methods as a prerequisite for valid study results. Eur J Epidemiol. 2008;23:761–5.CrossRefPubMed Stang A. Appropriate epidemiologic methods as a prerequisite for valid study results. Eur J Epidemiol. 2008;23:761–5.CrossRefPubMed
15.
go back to reference Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–220. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–220.
16.
go back to reference Clayton D, Hills M. Statistical models in epidemiology. New York: Oxford University Press; 1993. Clayton D, Hills M. Statistical models in epidemiology. New York: Oxford University Press; 1993.
17.
go back to reference Hofman A, Breteler MMB, van Duijn CM, Janssen HLA, Krestin GP, Kuipers EJ, et al. The Rotterdam study: 2010 objectives and design update. Eur J Epideiol. 2009;24:553–72.CrossRef Hofman A, Breteler MMB, van Duijn CM, Janssen HLA, Krestin GP, Kuipers EJ, et al. The Rotterdam study: 2010 objectives and design update. Eur J Epideiol. 2009;24:553–72.CrossRef
18.
go back to reference Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139:476–82.PubMed Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139:476–82.PubMed
19.
go back to reference Robins JM. Estimation of the time-dependent accelerated failure time model in the presence of confounding factors. Biometrika. 1992;79:321–34.CrossRef Robins JM. Estimation of the time-dependent accelerated failure time model in the presence of confounding factors. Biometrika. 1992;79:321–34.CrossRef
20.
go back to reference Young JG, Hernán MA, Picciotto S, Robins JM. Relation between three classes of structural models for the effect of a time-varying exposure on survival. Lifetime Data Anal. 2009 Nov 6 (Epub ahead of print). Young JG, Hernán MA, Picciotto S, Robins JM. Relation between three classes of structural models for the effect of a time-varying exposure on survival. Lifetime Data Anal. 2009 Nov 6 (Epub ahead of print).
Metadata
Title
Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies
Authors
B. H. Ch. Stricker
T. Stijnen
Publication date
01-04-2010
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 4/2010
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-010-9451-7

Other articles of this Issue 4/2010

European Journal of Epidemiology 4/2010 Go to the issue